MedPath

Noninvasive Spinal Neuromodulation Enables Locomotor Recovery in Individuals With Cerebral Palsy

Phase 1
Recruiting
Conditions
Cerebral Palsy
Registration Number
NCT04882592
Lead Sponsor
SpineX Inc.
Brief Summary

Assessing the effects of noninvasive spinal cord neuromodulation on improving function in individuals with cerebral palsy

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
    1. individuals above the age of 2 years of age and 2) diagnosed with cerebral palsy (CP). The exclusion criteria included 1) children with selective dorsal root rhizotomy, 2) intramuscular Botox injection in the preceding 12 months, 3) current antispastic medications 4) unhealed fractures or contractures that would prevent them from performing functional tasks and 5) tendon lengthening surgeries.
Exclusion Criteria
  • Intramuscular Botox injection in the past 12 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Gross Motor Functional Measure (GMFM)3 months
Stepping overground or on a treadmill3 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

SpineX

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

SpineX
πŸ‡ΊπŸ‡ΈLos Angeles, California, United States
Parag Gad, PhD
Contact
408-203-5061
parag@spinex.co

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.